Connect with us

Hi, what are you looking for?


Teladoc stock: cautiously optimistic even as insiders dump shares

Teladoc (NYSE: TDOC) stock price has bounced back recently as investors anticipate a potential pivot of the Federal Reserve. The shares jumped by more than 10% on Tuesday as it reached the highest point since February. In all, they have soared by more than 33% from last year’s lows.

TDOC insiders are selling shares

Teladoc share price has been recovering because of three key reasons. First, some investors believe that the company has become incredibly undervalued. It has a market cap of more than $4.7 billion, which is lower than its all-time high of over $25 billion. As a reminder, Teladoc acquired Livongo Health in a $17 billion deal.

Second, the shares have risen because of the company’s growing market share in the telehealth industry. For example, Betterhelp, a company that had $100 million in 2019 is now generating over $1 billion as demand for mental health rises.

On Tuesday, TDOC stock jumped after the company said that it will launch a new service for weight management and prediabetes programs. These are large industries that could generate millions of dollars in the next few years.

Further, like other technology companies, Teladoc stock has jumped as investors cheer the potential of a Fed pivot. There is a likelihood that the bank will stop hiking rates in the coming months since inflation seems like it has peaked. This also explains why the US dollar has dropped while cryptocurrencies have jumped.

However, the main risk for Teladoc is that its insiders are selling shares. In most cases, insiders exit when they are expecting bad things to happen. It has been widely reported that Silicon Valley Bank executives sold shares before the collapse.

Data compiled by MarketBeat shows that senior executives have been selling shares for years. In March, the company’s CEO sold stock worth over $571k. In all, insiders have sold shares worth over $1.17 million in the past 12 months. No insider has bought shares in this period.

Teladoc stock price forecast

On the daily chart, we see that the TDOC stock price bottomed at $22.56, where it failed to move below several times since 2022. The shares have now moved above the 50-day moving average and formed a small inverted head and shoulders pattern.

Therefore, for now, I am cautiously optimistic about the company’s shares, with the next key level to watch being at $34.24, the highest point on February 1. A move above the key support at $25 will invalidate the bullish view.

The post Teladoc stock: cautiously optimistic even as insiders dump shares appeared first on Invezz.

Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.

    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    You May Also Like

    Latest News

    Rep. Jennifer Wexton (D-Va.) announced on Tuesday that she has been diagnosed with Parkinson’s Disease. “If there’s one thing that Democrats and Republicans can...

    Latest News

    After Dianne Feinstein announced she’d contracted the shingles in early March, her staff said she planned to return to the Senate within a matter...


    A U.S. District Court judge has ruled that Elizabeth Holmes, founder and CEO of the disgraced blood-testing company Theranos, cannot remain free on bail...

    Latest News

    SEOUL, South Korea — When a group of American lawmakers arrived in South Korea for meetings with government and military officials, President Yoon Suk-yeol...

    Disclaimer:, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2022 All Rights Reserved.